Navigation Links
Lecture to honor victim of Sept. 11 tragedy
Date:9/11/2007

Boston, MA--Boston University School of Medicine (BUSM) will present The Sixth Annual Sue Kim Hanson Lecture in Immunology on Friday, September 14, 2007 at noon. The annual lecture is in honor of Sue Kim Hanson, MA, PhD 02, a former researcher in BUSMs Pulmonary Center. Kim Hanson, along with her husband and daughter, were passengers on United Airline flight 175, the second plane that struck the World Trade Center on September 11, 2001.

The lecture titled, Mechanisms of Signal Integration in Innate Immunity, will focus on how innate immune cells respond to viral infections by directing the synthesis of anti-viral proteins. It will be presented by Tom Maniatis, PhD, the Thomas H. Lee professor of molecular and cellular biology at Harvard University.

Maniatis has been an international leader in the fields of molecular and cellular biology where his studies have provided critical insights regarding mechanisms of RNA transcription, pre-mRNA splicing and signal transduction. In 1982 he co-authored Molecular Cloning-A Laboratory Manual, a text that revolutionized the way modern biological research is conducted in the laboratory. His current research explores the regulation of innate immunity and the role of gene expression in brain development and function.

Kim Hanson moved to Boston and earned a MA degree in medical sciences from BUSM in 1992. After graduation, she joined the Schools Pulmonary Center. She then concurrently entered the PhD program in the department of pathology and laboratory medicine at BUSM.

Her thesis project was an investigation of the role of interleukin-16 in immunity and targeted deletion of the interleukin-16 gene in mice. Her degree was awarded posthumously by unanimous vote by the thesis committee.

Sue was on her way to a promising career in molecular biology, said David Center, MD, Gordon and Ruth Snider Professor of Pulmonary Medicine, Professor of Medicine and Biochemistry at BUSM. While her life was taken at an early age, her legacy lives on through this annual lecture. We are proud to remember and honor her and her family each year.


'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8491
Boston University
Source:Eurekalert

Related biology news :

1. APS lecturer shows rare video of teacher-student immune cell interactions in live animal
2. Old dinosaur research leads to new honor
3. New tooth enamel dating technique could help identify disaster victims
4. Spray-on skin relieves emotional trauma for child burn victims
5. Malaria vaccine prompts victims immune system to eliminate parasite from mosquitoes
6. Traumas like Sept. 11 make brains more reactive to fear
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2017)... Feb. 14, 2017  Wake Forest Baptist Medical Center ... new chief executive officer (CEO). Freischlag joins the medical ... D. McConnell , M.D., who last year announced that ... Medical Center, after leading it since 2008.   ... of Wake Forest Baptist,s academic health system, which includes ...
(Date:2/13/2017)... 2017 Former 9/11 Commission border counsel and ... Janice Kephart of Identity Strategy Partners, LLP, today ... "Executive Order: Protecting the Nation From Foreign Terrorist ... "As President Trump,s ,Travel Ban, Executive Order gains ... banned the travel ban, it is important that our ...
(Date:2/9/2017)... LONDON , Feb. 9, 2017 The ... in-depth analysis of the biomass boiler market globally in ... sales of biomass boilers. The market for biomass boilers ... product type, end-user, application, and country/region. The market based ... agriculture & forest residues, biogas & energy crops, urban ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
(Date:2/23/2017)... - The Fight Against Cancer Innovation Trust (FACIT) and ... to report that Fusion Pharmaceuticals Inc. (Fusion) has closed ... Innovation – JJDC, Inc. (JJDC) as the lead investor. ... Partners, and Genesys Capital, as well as founding investor ... ...
(Date:2/23/2017)... Feb. 23, 2017  Imanis Life Sciences announced ... of oncolytic vaccinia viruses for virotherapy research. These ... of Genelux,s proprietary, vaccinia virus-based technology platform for ... enter into a partnership with Genelux to offer ... viruses for use in research," said Dr. ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... as insulin, cortisol, CRP, adiponectin, uric acid, and/or other biomarkers or SNPs of ... Assay from Salimetrics’ SalivaLab , the relationship between insulin and other relevant ...
Breaking Biology Technology: